Halo Collective Inc (HCANF)
0.0001
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Halo Collective Cash from Financing (Quarterly): -0.4607M for June 30, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -0.4607M |
| March 31, 2023 | 1.408M |
| December 31, 2022 | 1.023M |
| September 30, 2022 | -0.1701M |
| June 30, 2022 | -0.1678M |
| March 31, 2022 | 10.39M |
| December 31, 2021 | 1.407M |
| September 30, 2021 | 11.34M |
| June 30, 2021 | 4.532M |
| March 31, 2021 | 15.90M |
| December 31, 2020 | 9.216M |
| September 30, 2020 | 0.7381M |
| June 30, 2020 | 0.2404M |
| March 31, 2020 | 0.1886M |
| December 31, 2019 | 3.476M |
| September 30, 2019 | 1.116M |
| June 30, 2019 | 15.29M |
| March 31, 2019 | 2.043M |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 |
| Date | Value |
|---|---|
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | -0.0139M |
| March 31, 2012 | 0.0167M |
| December 31, 2011 | 0.4589M |
| September 30, 2011 | 0.2559M |
| June 30, 2011 | 24.77M |
| March 31, 2011 | 1.322M |
| December 31, 2010 | 6.409M |
| September 30, 2010 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.4607M
Minimum
Jun 2023
15.90M
Maximum
Mar 2021
4.439M
Average
1.407M
Median
Dec 2021
Cash from Financing (Quarterly) Benchmarks
| CEN Biotech Inc | 0.00 |
| Acasti Pharma Inc | 0.00 |
| Aurinia Pharmaceuticals Inc | -5.577M |
| Edesa Biotech Inc | 0.2117M |
| Lexaria Bioscience Corp | 3.453M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.4658M |
| Cash from Investing (Quarterly) | 0.4945M |
| Free Cash Flow | -4.181M |
| Free Cash Flow Per Share (Quarterly) | -0.0031 |
| Free Cash Flow to Equity (Quarterly) | -0.8621M |
| Free Cash Flow to Firm (Quarterly) | -0.2378M |